Entrepreneur

This was followed in 2005 by founding Trimega Laboratories, which revolutionised the way alcohol testing was conducted in the United Kingdom. It was selected to represent the UK at the European Business Awards and was recognised as 'World Leading' by the Society of Hair Testing, the industry’s self-regulated body.

Avi’s third venture, DNAfit was a self-funded health tech disruptor created in 2013 and one of the first companies to pioneer at home genetic testing that is widely available in a direct-to-consumer setting.

DNAfit achieved many accolades in the UK including two coveted Queen’s Awards for Enterprise in 2018 for international trade and innovation while also attracting investment and endorsement from former Manchester United defender and England captain Rio Ferdinand.

Avi successfully sold DNAfit for $10m to Hong Kong’s Prenetics Group, a major global diagnostics and genetic testing company with the mission to decentralise healthcare and bring health closer to millions of people globally.

As CEO EMEA for Prenetics, Avi played a key role in its successful IPO on the Nasdaq in May 2022 - the first time a Hong Kong company achieved unicorn status, with a $1bn plus listing. Avi’s UK-based division of Prenetics had achieved more than 50% of the group’s global $275m revenues in 2021.